Legal & RegulatoryEvent: September 6, 2026
Kaleidex Group highlighted that the MHRA explored a potential development of a medical device licencing regime requiring a license issued by the MHRA rather than relying solely on third-party conformity assessment.
Published
Signal category
Legal & Regulatory
Quote
“The one that caught my attention is the potential development of a medical device licencing regime.”
— Mufeeda C.|Kaleidex Group team
Company
Kaleidex Group
Uniting expertise to streamline manufacturing innovation
- Industry
- Medical Equipment Manufacturing
- Location
- London, GB
- Company size
- 26 employees
Creating a leading group of high-quality medical contract manufacturers that set the standard for excellence within the industry.